These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9738772)

  • 1. Toxin-mediated streptococcal and staphylococcal disease.
    Manders SM
    J Am Acad Dermatol; 1998 Sep; 39(3):383-98; quiz 399-400. PubMed ID: 9738772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
    Smith RJ; Schlievert PM; Himelright IM; Baddour LM
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent toxin-mediated perineal erythema.
    Manders SM; Heymann WR; Atillasoy E; Kleeman J; Schlievert PM
    Arch Dermatol; 1996 Jan; 132(1):57-60. PubMed ID: 8546484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of streptococcal and staphylococcal toxinic diseases].
    Floret D
    Arch Pediatr; 2001 Sep; 8 Suppl 4():762s-768s. PubMed ID: 11582925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS.
    Cone LA; Woodard DR; Byrd RG; Schulz K; Kopp SM; Schlievert PM
    J Infect Dis; 1992 Apr; 165(4):638-43. PubMed ID: 1552193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent toxin-mediated perineal erythema: eleven pediatric cases.
    Patrizi A; Raone B; Savoia F; Ricci G; Neri I
    Arch Dermatol; 2008 Feb; 144(2):239-43. PubMed ID: 18283182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of streptococcal and staphylococcal superantigens in septic shock.
    Bannan J; Visvanathan K; Zabriskie JB
    Infect Dis Clin North Am; 1999 Jun; 13(2):387-96, ix. PubMed ID: 10340173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular structure of staphylococcus and streptococcus superantigens.
    Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
    J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Leung DY; Meissner HC; Fulton DR; Murray DL; Kotzin BL; Schlievert PM
    Lancet; 1993 Dec; 342(8884):1385-8. PubMed ID: 7901681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcal superantigens: categorization and clinical associations.
    Commons RJ; Smeesters PR; Proft T; Fraser JD; Robins-Browne R; Curtis N
    Trends Mol Med; 2014 Jan; 20(1):48-62. PubMed ID: 24210845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolysins augment superantigen penetration of stratified mucosa.
    Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
    J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic shock syndrome in children: epidemiology, pathogenesis, and management.
    Chuang YY; Huang YC; Lin TY
    Paediatr Drugs; 2005; 7(1):11-25. PubMed ID: 15777108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
    Schlievert PM
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S107-10. PubMed ID: 11586276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease and toxic shock syndrome--at last the etiology is clear?
    Curtis N
    Adv Exp Med Biol; 2004; 549():191-200. PubMed ID: 15250533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
    Matsubara K; Fukaya T
    Curr Opin Infect Dis; 2007 Jun; 20(3):298-303. PubMed ID: 17471041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the cytokine network in a patient with AIDS and the recalcitrant erythematous desquamating disorder.
    Dondorp AM; Veenstra J; van der Poll T; Mulder JW; Reiss P
    Clin Infect Dis; 1994 Jun; 18(6):942-5. PubMed ID: 8086557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gram-positive septic-toxic shock with bullae. Intraepidermal splitting as an indication of toxin effect].
    Buslau M; Biermann H; Shah PM
    Hautarzt; 1996 Oct; 47(10):783-9. PubMed ID: 9036130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxic shock syndrome].
    Hansen NS; Leth S; Nielsen LT
    Ugeskr Laeger; 2020 May; 182(20):. PubMed ID: 32400378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.